CIK: 0001582384
Total reported value
$106.2M
Reporting period: 2026-03-31 · Number of holdings: 2
Wildcat Capital Management, LLC disclosed 2 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $106.2M and a quarterly turnover rate of 30.1%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "W"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add ALLO
0.0% $3.1M
Trim ULCC
0.0% -$33.1M
Sold out PCOR
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ULCC | Frontier Group Holdings INC | Stock-Other | 93.29% | -3.57% | — | |
| 2 | ALLO | Allogene Therapeutics INC | Stock-Other | 6.71% | +3.78% | — |
Performance for Q3 2026
+66.4%
Performance Last 4 Quarters
+39.5%
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 2 | $106.2M | 30 | |
| 2025-12-31 | 3 | $136.5M | 19 | |
| 2025-09-30 | 5 | $145.1M | 31 | |
| 2025-06-30 | 6 | $168.3M | 0 | |
| 2025-03-31 | 8 | $187.4M | 100 | |
| 2024-12-31 | 8 | $252.7M | 0 | |
| 2024-09-30 | 7 | $204.6M | 0 | |
| 2024-06-30 | 16 | $408.6M | 0 | |
| 2024-03-31 | 16 | $275.5M | 0 | |
| 2023-12-31 | 20 | $289.2M | 0 | |
| 2023-09-30 | 20 | $249.0M | 0 | |
| 2023-06-30 | 17 | $262.8M | 0 | |
| 2023-03-31 | 22 | $269.1M | 0 | |
| 2022-12-31 | 28 | $261.9M | 0 | |
| 2022-09-30 | 30 | $260.2M | 0 | |
| 2022-06-30 | 27 | $301.9M | 0 | |
| 2022-03-31 | 25 | $390.8M | 0 | |
| 2021-12-31 | 24 | $614.1M | 0 | |
| 2021-09-30 | 25 | $772.3M | 0 | |
| 2021-06-30 | 21 | $881.3M | 23 | |
| 2021-03-31 | 25 | $818.8M | 16 | |
| 2020-12-31 | 27 | $795.8M | 100 | |
| 2020-09-30 | 25 | $312.8M | 27 | |
| 2020-06-30 | 36 | $289.5M | 72 | |
| 2020-03-31 | 23 | $219.6M | 66 | |
| 2019-12-31 | 31 | $346.6M | 50 | |
| 2019-09-30 | 30 | $235.4M | 47 | |
| 2019-06-30 | 32 | $231.1M | 42 | |
| 2019-03-31 | 24 | $170.6M | 58 | |
| 2018-12-31 | 22 | $152.1M | 50 | |
| 2018-09-30 | 21 | $129.6M | 24 | |
| 2018-06-30 | 19 | $130.7M | 16 | |
| 2018-03-31 | 16 | $121.2M | 40 | |
| 2017-12-31 | 13 | $94.0M | 100 | |
| 2017-09-30 | 20 | $557.6M | 50 | |
| 2017-06-30 | 21 | $376.1M | 43 | |
| 2017-03-31 | 19 | $315.7M | 57 | |
| 2016-12-31 | 18 | $217.4M | 54 | |
| 2016-09-30 | 30 | $331.8M | 37 | |
| 2016-06-30 | 29 | $265.3M | 35 | |
| 2016-03-31 | 28 | $287.5M | 46 | |
| 2015-12-31 | 26 | $354.4M | 29 | |
| 2015-09-30 | 26 | $267.9M | 54 | |
| 2015-06-30 | 24 | $291.7M | 41 | |
| 2015-03-31 | 16 | $258.1M | 24 | |
| 2014-12-31 | 13 | $243.0M | 0 |
Wildcat Capital Management, LLC's most significant position changes for 2026-03-31: Sold out: Procore Technologies INC (PCOR).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ALLO | Allogene Therapeutics INC | +3.8% | — | Unchanged |
| 2 | ULCC | Frontier Group Holdings INC | -3.6% | — | Unchanged |
| 3 | PCOR | Procore Technologies INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-01 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-03 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-07-18 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-02 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-01-29 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-08 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-14 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-13 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-09 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-11 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-08-10 | Amendment | View on EDGAR |
| 2023-03-31 | 2023-05-12 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-07 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-08 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-11-08 | Amendment | View on EDGAR |
| 2022-06-30 | 2022-08-05 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-13 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-17 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-12 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-13 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-14 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-04-09 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-14 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-14 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-15 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-13 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-13 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-13 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-15 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-15 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-09 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-12-02 | Amendment | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-12-02 | Amendment | View on EDGAR |
| 2016-06-30 | 2016-08-11 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-12-02 | Amendment | View on EDGAR |
| 2016-03-31 | 2016-05-13 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-12-02 | Amendment | View on EDGAR |
| 2015-12-31 | 2016-02-16 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-16 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-08-14 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-05-08 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-02-13 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0002110449
Total reported value
$106.2M
22 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002097516
Total reported value
$106.2M
568 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002093991
Total reported value
$106.2M
31 stks
2026-03-31
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0000078003
Total reported value
$238.8M
21 stks
2026-03-31
1 of the top 5 holdings overlap, including Allogene Therapeutics INC
CIK 0001495741
Total reported value
$10.1B
51 stks
2021-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Allogene Therapeutics INC
CIK 0001735804
Total reported value
$114.0M
4 stks
2020-06-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Allogene Therapeutics INC